Prolynx names CFO and CSO to advance obesity drug portfolio
Go back to Prolynx names CFO and CSO to advance obesity drug portfolio| (NASDAQ: CLLS) | Delayed: 3.41 -0.06 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.47 | 52 Week High | $37.55 | |||
| Open | $3.33 | 52 Week Low | $16.35 | |||
| Day High | $3.48 | P/E | N/A | |||
| Day Low | $3.20 | EPS | $0.00 | |||
| Volume | 26,655 | |||||
| Ram Gold & Exploration, Inc. (NASDAQ: MGX) | Delayed: 1.23 +0.03 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.20 | 52 Week High | $0.65 | |||
| Open | $1.22 | 52 Week Low | $0.65 | |||
| Day High | $1.26 | P/E | N/A | |||
| Day Low | $1.20 | EPS | $0.00 | |||
| Volume | 303,195 | |||||
